Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare
Seres Therapeutics, Inc. Total Liabilities 2015–2025
Seres Therapeutics, Inc. annual total liabilities history from 2015 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Seres Therapeutics, Inc. total liabilities as of December 31, 2025: 94.0M, a 25.43% decrease year-over-year.
- Seres Therapeutics, Inc. total liabilities for 2025 were 94.0M, a 25.43% decrease from 2024.
- Seres Therapeutics, Inc. total liabilities for 2024 were 126.0M, a 68.76% decrease from 2023.
- Seres Therapeutics, Inc. total liabilities for 2023 were 403.5M, a 19.37% increase from 2022.
- Seres Therapeutics, Inc. total liabilities for 2022 were 338.0M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Seres Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $94 |
| 2024 | $126 |
| 2023 | $403 |
| 2022 | $338 |
| 2021 | $223 |
| 2020 | $168 |
| 2019 | $181 |
| 2018 | $169 |
| 2017 | $129 |
| 2016 | $140 |
| 2015 | $12 |
Seres Therapeutics, Inc. Total Liabilities — FAQ
Seres Therapeutics, Inc. (MCRB) total liabilities over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MCRB's total liabilities history?
The chart and table above show Seres Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.